Search and volunteer to participate in these available studies at UB. Your participation in research doesn't just benefit you, it helps advance healthcare for our entire community.

Highlighted Searches
Search Clinical Trials
Filter on any fields below
?
Compensation may include cash, checks, gift cards, debit cards, or incentives like gift baskets, technology items, or merchandise.
Showing 21 - 30 of 310 Clinical Trials
Description:
This study enrolls people with TRK fusion cancer. The purpose of this study is to learn more about the effectiveness of the drug VITRAKVI (generic name: larotrectinib) for TRK fusion cancer that has spread from the place where it started to other places in the body. TRK fusion cancer is a term used to describe a variety of common and rare cancers that are caused by a change to the NTRK (Neurotrophic Tyrosine Kinase) gene called a fusion. VITRAKVI is an approved drug that blocks the action of the NTRK gene fusion. Read More
Eligibility:
Adults 18+
Patients with TRK fusion cancer (locally advanced or metastatic solid tumor harboring an NTRK gene fusion).
Your physician has decided to treat you with larotrectinib.
Contact(s)
Deonna Coleman
dc84@buffalo.edu
Description:
This study enrolls adults with esophageal cancer. The purpose of this study is to compare the effects of different combinations of medications to treat this cancer. Atezolizumab and tiragolumab are experimental drugs, which means the U.S. Food and Drug Administration (FDA) has not approved them, alone or in combination, for the treatment of esophageal cancer. Read More
Eligibility:
Adults ages 18+.
Diagnosed with esophageal cancer (squamous cell carcinoma of the esophagus) in stage II-IIVA.
The cancer is unresectable, which means you are unable to unwilling to have surgery.
You have received chemoradiotherapy and your disease did not worsen.
Contact(s)
Deonna Coleman
dc84@buffalo.edu
Description:
This study enrolls adults who have been diagnosed with borderline personality disorder. This study is being done to see if the study drug called, BI 1358894, may help people with BPD in the future. Read More
Eligibility:
Adults ages 18-65 years.
Diagnosed with Borderline Personality Disorder.
Contact(s)
SEVIE KANDEFER
sk293@buffalo.edu
+1 716-898-4038
Description:
This study enrolls children and teens. The purpose of the study is to see which types of toothpaste give the most benefit to teeth. Read More
Eligibility:
Children ages 10-14.
Presence of second molars or evidence of erupting permanent second molars.
Good general health
Contact(s)
ALLANA LANGEN
alangen@buffalo.edu
+1 716-888-4712
Description:
This study enrolls people with Multiple Sclerosis who have already enrolled in the New York State Multiple Sclerosis Consortium (NYSMSC). The purpose of this study is to learn more about the experiences of people with MS who are having a natalizumab infusion. Read More
Eligibility:
Adults ages 18+.
Have multiple sclerosis.
Are enrolled in the New York State Multiple Sclerosis Consortium (NYSMSC),
Have taken natalizumab for the treatment of MS for at least six months.
Contact(s)
CAILA VAUGHN
hilbert2@buffalo.edu
+1 716-859-3393
Description:
This study enrolls adults ages 18-45. The purpose of this study is to learn more about people's thoughts about the future and exercise. Read More
Eligibility:
Adults ages 18-45.
Have access to smartphone or wi-fi connected tablet.
Are able to do moderate physical activity.
Contact(s)
CATHERINE GUTH
ciguth@buffalo.edu
+1 716-829-5666
Description:
This study enrolls medical students, residents, and attending physicians. The purpose of the study is to learn how effective a remove microsurgery coach is to improve technical skills. Read More
Eligibility:
Adults ages 18+.
Fourth year medical students, residents, fellow physicians, and junior attendings in the general surgery, otolaryngology, vascular surgery, and head and neck surgery programs.
Contact(s)
Brian Quaranto
brianqua@buffalo.edu
Description:
This study enrolls adults who come to the Buffalo General Medical Center emergency department who may have COVID-19. The purpose of this research study is to help us find a way to learn which patients are at risk of developing a severe COVID-19 infection versus a less severe COVID-19 infection. We will do this by looking at immune cells in blood. Read More
Eligibility:
Adults ages 18+.
Come to the emergency department at Buffalo General Medical Center with suspicion of COVID-19.
This study is not open for open enrollment- you may be invited to participate if you meet other eligibility criteria and are at the BGMC emergency department.
Description:
This study enrolls adults who have had heart failure or heart attack or who are generally healthy. The purpose of this study is to learn more about how these types of cardiovascular issues happen at a biological level. We will do that by looking at the immune cells in the blood. Read More
Eligibility:
Adults ages 18+
Generally healthy OR are presenting to the hospital with heart failure or acute myocardial infarction (heart attack).
Contact(s)
KYLE MENTKOWSKI
kylement@buffalo.edu
+1 716-645-8500
Description:
This study enrolls older adults ages 60+. We are looking for adults who are not active who have Type 2 Diabetes and also physically active older adults. The purpose of the study is to learn if a 2-month home-based exercise program will help improve oxygen levels and fitness. Read More
Eligibility:
Adults ages 60+.
Able to walk and follow simple exercise instruction.

Two groups will be enrolled:
1. People with Type 2 Diabetes with a low level of physical activity right now.
2. Physically active people (do cycling, strength training or walking faster than usual for 60+ minutes per week) with or without type 2 diabetes.
Contact(s)
Showing 21 - 30 of 310 Clinical Trials
Not finding what you are looking for? Add your profile to the Buffalo Research Registry or ResearchMatch to be matched with future studies.